Global Psoriasis Drug Market Insights, Forecast to 2025


Psoriasis is a long-lasting autoimmune disease which is characterized by patches of abnormal skin.
The global Psoriasis Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Psoriasis Drug market based on company, product type, end user and key regions.

This report studies the global market size of Psoriasis Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Psoriasis Drug in these regions.
This research report categorizes the global Psoriasis Drug market by top players/brands, region, type and end user. This report also studies the global Psoriasis Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    AbbVie
    Johnson & Johnson
    Bayer
    Galderma
    Bristol-Myers Squibb
    Novartis
    Pfizer
    Merz Pharma
    Valeant
    LEO Pharma
    GlaxoSmithKline

Market size by Product
    External Use
    Oral
    Injection
Market size by End User
    Hospital
    Drugs Store

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Psoriasis Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Psoriasis Drug market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Psoriasis Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Psoriasis Drug submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Psoriasis Drug are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Psoriasis Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1  Psoriasis Drug Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Psoriasis Drug Market Size Growth Rate by Product
        1.4.2 External Use
        1.4.3 Oral
        1.4.4 Injection
    1.5 Market by End User
        1.5.1 Global Psoriasis Drug Market Size Growth Rate by End User
        1.5.2 Hospital
        1.5.3 Drugs Store
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Psoriasis Drug Market Size
        2.1.1 Global Psoriasis Drug Revenue 2014-2025
        2.1.2 Global Psoriasis Drug Sales 2014-2025
    2.2 Psoriasis Drug Growth Rate by Regions
        2.2.1 Global Psoriasis Drug Sales by Regions
        2.2.2 Global Psoriasis Drug Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Psoriasis Drug Sales by Manufacturers
        3.1.1 Psoriasis Drug Sales by Manufacturers
        3.1.2 Psoriasis Drug Sales Market Share by Manufacturers
        3.1.3 Global Psoriasis Drug Market Concentration Ratio (CR5 and HHI)
    3.2 Psoriasis Drug Revenue by Manufacturers
        3.2.1 Psoriasis Drug Revenue by Manufacturers (2014-2019)
        3.2.2 Psoriasis Drug Revenue Share by Manufacturers (2014-2019)
    3.3 Psoriasis Drug Price by Manufacturers
    3.4 Psoriasis Drug Manufacturing Base Distribution, Product Types
        3.4.1 Psoriasis Drug Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Psoriasis Drug Product Type
        3.4.3 Date of International Manufacturers Enter into Psoriasis Drug  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Psoriasis Drug Sales by Product
    4.2 Global Psoriasis Drug Revenue by Product
    4.3 Psoriasis Drug Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Psoriasis Drug Breakdown Data by End User

6 North America
    6.1 North America Psoriasis Drug by Countries
        6.1.1 North America Psoriasis Drug Sales by Countries
        6.1.2 North America Psoriasis Drug Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Psoriasis Drug by Product
    6.3 North America Psoriasis Drug by End User

7 Europe
    7.1 Europe Psoriasis Drug by Countries
        7.1.1 Europe Psoriasis Drug Sales by Countries
        7.1.2 Europe Psoriasis Drug Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Psoriasis Drug by Product
    7.3 Europe Psoriasis Drug by End User

8 Asia Pacific
    8.1 Asia Pacific Psoriasis Drug by Countries
        8.1.1 Asia Pacific Psoriasis Drug Sales by Countries
        8.1.2 Asia Pacific Psoriasis Drug Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Psoriasis Drug by Product
    8.3 Asia Pacific Psoriasis Drug by End User

9 Central & South America
    9.1 Central & South America Psoriasis Drug by Countries
        9.1.1 Central & South America Psoriasis Drug Sales by Countries
        9.1.2 Central & South America Psoriasis Drug Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Psoriasis Drug by Product
    9.3 Central & South America Psoriasis Drug by End User

10 Middle East and Africa
    10.1 Middle East and Africa Psoriasis Drug by Countries
        10.1.1 Middle East and Africa Psoriasis Drug Sales by Countries
        10.1.2 Middle East and Africa Psoriasis Drug Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Psoriasis Drug by Product
    10.3 Middle East and Africa Psoriasis Drug by End User

11 Company Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Details
        11.1.2 Company Business Overview
        11.1.3 AbbVie Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 AbbVie Psoriasis Drug Products Offered
        11.1.5 AbbVie Recent Development
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Company Details
        11.2.2 Company Business Overview
        11.2.3 Johnson & Johnson Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Johnson & Johnson Psoriasis Drug Products Offered
        11.2.5 Johnson & Johnson Recent Development
    11.3 Bayer
        11.3.1 Bayer Company Details
        11.3.2 Company Business Overview
        11.3.3 Bayer Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Bayer Psoriasis Drug Products Offered
        11.3.5 Bayer Recent Development
    11.4 Galderma
        11.4.1 Galderma Company Details
        11.4.2 Company Business Overview
        11.4.3 Galderma Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Galderma Psoriasis Drug Products Offered
        11.4.5 Galderma Recent Development
    11.5 Bristol-Myers Squibb
        11.5.1 Bristol-Myers Squibb Company Details
        11.5.2 Company Business Overview
        11.5.3 Bristol-Myers Squibb Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Bristol-Myers Squibb Psoriasis Drug Products Offered
        11.5.5 Bristol-Myers Squibb Recent Development
    11.6 Novartis
        11.6.1 Novartis Company Details
        11.6.2 Company Business Overview
        11.6.3 Novartis Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Novartis Psoriasis Drug Products Offered
        11.6.5 Novartis Recent Development
    11.7 Pfizer
        11.7.1 Pfizer Company Details
        11.7.2 Company Business Overview
        11.7.3 Pfizer Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Pfizer Psoriasis Drug Products Offered
        11.7.5 Pfizer Recent Development
    11.8 Merz Pharma
        11.8.1 Merz Pharma Company Details
        11.8.2 Company Business Overview
        11.8.3 Merz Pharma Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 Merz Pharma Psoriasis Drug Products Offered
        11.8.5 Merz Pharma Recent Development
    11.9 Valeant
        11.9.1 Valeant Company Details
        11.9.2 Company Business Overview
        11.9.3 Valeant Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Valeant Psoriasis Drug Products Offered
        11.9.5 Valeant Recent Development
    11.10 LEO Pharma
        11.10.1 LEO Pharma Company Details
        11.10.2 Company Business Overview
        11.10.3 LEO Pharma Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
        11.10.4 LEO Pharma Psoriasis Drug Products Offered
        11.10.5 LEO Pharma Recent Development
    11.11 GlaxoSmithKline

12 Future Forecast
    12.1 Psoriasis Drug Market Forecast by Regions
        12.1.1 Global Psoriasis Drug Sales Forecast by Regions 2019-2025
        12.1.2 Global Psoriasis Drug Revenue Forecast by Regions 2019-2025
    12.2 Psoriasis Drug Market Forecast by Product
        12.2.1 Global Psoriasis Drug Sales Forecast by Product 2019-2025
        12.2.2 Global Psoriasis Drug Revenue Forecast by Product 2019-2025
    12.3 Psoriasis Drug Market Forecast by End User
    12.4 North America Psoriasis Drug Forecast
    12.5 Europe Psoriasis Drug Forecast
    12.6 Asia Pacific Psoriasis Drug Forecast
    12.7 Central & South America Psoriasis Drug Forecast
    12.8 Middle East and Africa Psoriasis Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Psoriasis Drug Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables and Figures Figure Psoriasis Drug Product Picture Table Psoriasis Drug Market Segments Table Key Manufacturers Psoriasis Drug Covered Table Global Psoriasis Drug Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Psoriasis Drug Sales Market Share by Product 2014-2025 Figure External Use Product Picture Table Major Manufacturers of External Use Figure Oral Product Picture Table Major Manufacturers of Oral Figure Injection Product Picture Table Major Manufacturers of Injection Table Global Psoriasis Drug Market Size Growth Rate by End User 2019-2025 (K Units) Figure Hospital Figure Drugs Store Figure Psoriasis Drug Report Years Considered Figure Global Psoriasis Drug Market Size 2014-2025 (Million US$) Figure Global Psoriasis Drug Sales 2014-2025 (K Units) Table Global Psoriasis Drug Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Psoriasis Drug Sales by Regions 2014-2019 (K Units) Table Global Psoriasis Drug Sales Market Share by Regions 2014-2019 Figure Global Psoriasis Drug Sales Market Share by Regions 2014-2019 Figure 2018 Global Psoriasis Drug Sales Market Share by Regions Table Global Psoriasis Drug Revenue by Regions 2014-2019 (Million US$) Table Global Psoriasis Drug Revenue Market Share by Regions 2014-2019 Figure Global Psoriasis Drug Revenue Market Share by Regions 2014-2019 Figure 2018 Global Psoriasis Drug Revenue Market Share by Regions Table Global Psoriasis Drug Sales by Manufacturers (2014-2019) (K Units) Table Global Psoriasis Drug Sales Share by Manufacturers (2014-2019) Figure Global Psoriasis Drug Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Psoriasis Drug Revenue by Manufacturers (2014-2019) (Million USD) Table Psoriasis Drug Revenue Share by Manufacturers (2014-2019) Figure Psoriasis Drug Value Share by Manufacturers in 2018 Table Key Manufacturers Psoriasis Drug Price (2014-2019) (USD/Unit) Table Psoriasis Drug Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Psoriasis Drug Product Type Table Date of International Manufacturers Enter into Psoriasis Drug Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Psoriasis Drug Sales by Product (2014-2019) (K Units) Table Global Psoriasis Drug Sales Share by Product (2014-2019) Figure Global Psoriasis Drug Sales Market Share by Product (2014-2019) Figure Global Psoriasis Drug Sales Market Share by Product in 2018 Table Global Psoriasis Drug Revenue by Product (2014-2019) (Million US$) Table Global Psoriasis Drug Revenue Share by Product (2014-2019) Figure Global Psoriasis Drug Revenue Market Share by Product (2014-2019) Figure Global Psoriasis Drug Revenue Market Share by Product in 2018 Table Psoriasis Drug Price by Product 2014-2019 (USD/Unit) Table Global Psoriasis Drug Sales by End User (2014-2019) (K Units) Table Global Psoriasis Drug Sales Share by End User (2014-2019) Figure Global Sales Psoriasis Drug Market Share by End User (2014-2019) Figure Global Sales Psoriasis Drug Market Share by End User in 2018 Figure North America Psoriasis Drug Sales Growth Rate 2014-2019 (K Units) Figure North America Psoriasis Drug Revenue Growth Rate 2014-2019 (Million US$) Table North America Psoriasis Drug Sales by Countries (2014-2019) (K Units) Table North America Psoriasis Drug Sales Market Share by Countries (2014-2019) Figure 2018 North America Psoriasis Drug Sales Market Share by Countries Table North America Psoriasis Drug Revenue by Countries (2014-2019) (Million US$) Table North America Psoriasis Drug Revenue Market Share by Countries (2014-2019) Figure 2018 North America Psoriasis Drug Revenue Market Share by Countries Figure United States Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure United States Psoriasis Drug Revenue Growth Rate (2014-2019) (K Units) Figure Canada Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Canada Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Mexico Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Table North America Psoriasis Drug Sales by Product (2014-2019) (K Units) Table North America Psoriasis Drug Sales Market Share by Product (2014-2019) Figure 2018 North America Psoriasis Drug Market Share by Product Table North America Psoriasis Drug Sales by End User (2014-2019) (K Units) Table North America Psoriasis Drug Sales Market Share by End User (2014-2019) Figure 2018 North America Psoriasis Drug Market Share by End User Figure Europe Psoriasis Drug Sales Growth Rate 2014-2019 (K Units) Figure Europe Psoriasis Drug Revenue Growth Rate 2014-2019 (Million US$) Table Europe Psoriasis Drug Sales by Countries (2014-2019) (K Units) Table Europe Psoriasis Drug Sales Market Share by Countries (2014-2019) Figure 2018 Europe Psoriasis Drug Sales Market Share by Countries Table Europe Psoriasis Drug Revenue by Countries (2014-2019) (Million US$) Table Europe Psoriasis Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Psoriasis Drug Revenue Market Share by Countries Figure Germany Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Germany Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure France Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure France Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure UK Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure UK Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Italy Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Russia Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Table Europe Psoriasis Drug Sales by Product (2014-2019) (K Units) Table Europe Psoriasis Drug Sales Market Share by Product (2014-2019) Figure 2018 Europe Psoriasis Drug Market Share by Product Table Europe Psoriasis Drug Sales by End User (2014-2019) (K Units) Table Europe Psoriasis Drug Sales Market Share by End User (2014-2019) Figure 2018 Europe Psoriasis Drug Market Share by End User Figure Asia Pacific Psoriasis Drug Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Psoriasis Drug Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Psoriasis Drug Sales by Countries (2014-2019) (K Units) Table Asia Pacific Psoriasis Drug Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Psoriasis Drug Sales Market Share by Countries Table Asia Pacific Psoriasis Drug Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Psoriasis Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Psoriasis Drug Revenue Market Share by Countries Figure China Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure China Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Japan Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Korea Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure India Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure India Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Australia Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Philippines Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Thailand Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Singapore Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Psoriasis Drug Sales by Product (2014-2019) (K Units) Table Asia Pacific Psoriasis Drug Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Psoriasis Drug Market Share by Product Table Asia Pacific Psoriasis Drug Sales by End User (2014-2019) (K Units) Table Asia Pacific Psoriasis Drug Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Psoriasis Drug Market Share by End User Figure Central & South America Psoriasis Drug Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Psoriasis Drug Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Psoriasis Drug Sales by Countries (2014-2019) (K Units) Table Central & South America Psoriasis Drug Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Psoriasis Drug Sales Market Share by Countries Table Central & South America Psoriasis Drug Revenue by Countries (2014-2019) (Million US$) Table Central & South America Psoriasis Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Psoriasis Drug Revenue Market Share by Countries Figure Brazil Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Brazil Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Argentina Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Psoriasis Drug Sales by Product (2014-2019) (K Units) Table Central & South America Psoriasis Drug Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Psoriasis Drug Market Share by Product Table Central & South America Psoriasis Drug Sales by End User (2014-2019) (K Units) Table Central & South America Psoriasis Drug Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Psoriasis Drug Market Share by End User Figure Middle East and Africa Psoriasis Drug Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Psoriasis Drug Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Psoriasis Drug Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Psoriasis Drug Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Psoriasis Drug Sales Market Share by Countries Table Middle East and Africa Psoriasis Drug Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Psoriasis Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Psoriasis Drug Revenue Market Share by Countries Figure GCC Countries Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Turkey Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure Egypt Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Psoriasis Drug Sales Growth Rate (2014-2019) (K Units) Figure South Africa Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Psoriasis Drug Sales by Product (2014-2019) (K Units) Table Middle East and Africa Psoriasis Drug Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Psoriasis Drug Market Share by Product Table Middle East and Africa Psoriasis Drug Sales by End User (2014-2019) (K Units) Table Middle East and Africa Psoriasis Drug Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Psoriasis Drug Market Share by End User Table AbbVie Company Details Table AbbVie Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table AbbVie Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Johnson & Johnson Recent Development Table Bayer Company Details Table Bayer Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Bayer Recent Development Table Galderma Company Details Table Galderma Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Galderma Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Bristol-Myers Squibb Recent Development Table Novartis Company Details Table Novartis Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Recent Development Table Pfizer Company Details Table Pfizer Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Recent Development Table Merz Pharma Company Details Table Merz Pharma Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Merz Pharma Recent Development Table Valeant Company Details Table Valeant Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Valeant Recent Development Table LEO Pharma Company Details Table LEO Pharma Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table LEO Pharma Recent Development Table GlaxoSmithKline Company Details Table Global Psoriasis Drug Sales Forecast by Regions 2019-2025 (K Units) Table Global Psoriasis Drug Sales Market Share Forecast by Regions 2019-2025 Table Global Psoriasis Drug Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Psoriasis Drug Revenue Market Share Forecast by Regions 2019-2025 Table Global Psoriasis Drug Sales Forecast by Product 2019-2025 (K Units) Table Global Psoriasis Drug Sales Market Share Forecast by Product 2019-2025 Table Global Psoriasis Drug Revenue Forecast by Product 2019-2025 (Million US$) Table Global Psoriasis Drug Revenue Market Share Forecast by Product 2019-2025 Table Global Psoriasis Drug Sales Forecast by End User 2019-2025 (K Units) Table Global Psoriasis Drug Sales Market Share Forecast by End User 2019-2025 Figure North America Psoriasis Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Psoriasis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Psoriasis Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Psoriasis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Psoriasis Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Psoriasis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Psoriasis Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Psoriasis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Psoriasis Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Psoriasis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Psoriasis Drug Value Chain Table Psoriasis Drug Customers List Table Psoriasis Drug Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global Pulp and Paper Chemical Market Insights and Forecast to 2026

Pulp and Paper Chemical market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pulp and Paper Chemical market will be able to gain the upper hand as they use the report as a powerful resource. The...

Global Polyurethane Resin Market Insights and Forecast to 2026

Polyurethane Resin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Polyurethane Resin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental...

Global Precious Metal Market Insights and Forecast to 2026

Precious Metal market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Precious Metal market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysi...

Global Polyamide Resin Market Insights and Forecast to 2026

Polyamide Resin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Polyamide Resin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analy...

Global PCB Laminate Market Size, Status and Forecast 2020-2026

PCB Laminate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PCB Laminate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis fo...

Publisher: QY Research
Chat with us